Markets
Palantir earnings
(Patrick T. Fallon/AFP via Getty Images)
eviscerated

Palantir surges as earnings blast past forecasts

The company, which joined the S&P 500 in September, is its third-best-performing stock this year.

Matt Phillips

Data-analytics and defense and intelligence contractor Palantir Technologies posted a record profit, driven in part by a surge in government revenues.

It was a smash bang quarter across the board as the company notched a record profit of $144 million on record revenue of $726 million, besting Wall Street forecasts on both fronts. Contract revenues from the US government rose 40% over the prior year to $320 million. Revenues to nongovernmental US buyers rose 54% to $179 million.

CEO Alex Karp spotlighted the company’s AI efforts — the company released its Artificial Intelligence Platform in 2023 — as a key accelerant to the company’s business.

"We are happy to see... the very, very strong results in US commercial; also, allied countries that have begun to realize that AI is the way in which to make their defenses superior in the face of brutal, heinous, immoral, and often terroristic enemies," Karp told analysts on a post-earnings conference call.

The stock surged in the after-hours trading session, putting it on pace to be up 170% so far in 2024. It is the third-best-performing stock in the S&P 500 on the year — trailing merchant power provider Vistra in the top spot, and Nvidia — after being added to the index in September.

More Markets

See all Markets
markets

IREN drops on convertible debt offering

Shares of crypto miner and AI compute provider IREN dropped after the Australia-based, US-listed company said late Tuesday that it would sell $875 million in convertible senior debt.

The announcement came late in the trading day and caused a sell-off in the aftermarket session that continued into Wednesday trading.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

markets

Tempus AI shares surge to all-time high

Shares of Tempus AI jumped over 7% Wednesday to reach an all-time high of $99.90. Shares of the AI medical diagnostics company are up over 191% for the year so far.

The company has recently announced a flurry of FDA clearances for its technologies. Most recently, on September 22, Tempus AI was granted FDA clearance for its Tempus xR IVD device, which is used to tailor cancer therapies.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.